All posts from Zacks
Zacks in Our Research. Your Success.,

Waters Corp. (WAT) Q1 Earnings and Revenues Top Estimates

Milford, Massachusetts-based Waters Corporation WAT is a prominent medical instrument supplying firm, conducting trade in the healthcare sector. The company is renowned analytical instrument producer but also builds up and supplies software-based products to its customers.

WAT’s global pharmaceuticals business, its largest single market and major revenue driver, has been gaining traction over the last few quarters and fuelling the growth of Waters Division. The company has a strong presence in the chromatography instrument and pharmaceuticals markets and expects to reap handsome profits from these markets. Additionally, research-intensive product launches coupled with its strong REIMS technology are showing strong future prospects.

However, WAT’s debt level remains a burden, given its recent acquisitions. Also, financial markets in certain foreign countries, especially in Eastern Europe, have been experiencing economic inconsistencies. Such challenging macro conditions, coupled with currency fluctuations, have restricted sales growth rate in recent times. WAT expects these concerns to persist and dampen some of its sales growth momentum to some extent.

Nevertheless, in the last four trailing quarters, WAT has reported a positive average earnings surprise of 6.3%, beating all through.

Currently, WAT has a Zacks Rank #2 (Buy) but that could change following its first-quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings: WAT beats on earnings. Adjusted earnings per share came in at $1.26, higher than the Zacks Consensus Estimate of $1.23.

Revenue: Revenues of $475 million came above the Zacks Consensus Estimate of $472 million.

Key Stats: Waters witnessed very strong sales growth in Asia which posted 11% growth in constant currency. Also strong demand from China and India added to the company’s bliss.

Stock Price: WAT shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
WATERS CORP (WAT): Free Stock Analysis Report
To read this article on click here.